David Brunk
Medical · Colorado Springs, CONPI 1982790150
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (53.5%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 33 manufacturers reported payments, led by Boston Scientific at 41.7% of the total. Among medical clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 372 payments — averaging $49.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$8K
- Atricure, Inc.$2K
- Medtronic$2K
- Novartis$962
- Pfizer$812
- E.r. Squibb & Sons, L.L.C.$734
- plus $4K from 27 others
What the payments were for
- Speaking & faculty fees$4,00022%
- Travel & lodging$4,53325%
- Food & beverage$9,80453%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 30 | $7,650 |
| Atricure, Inc. | 12 | $2,218 |
| Medtronic | 11 | $1,648 |
| Novartis | 48 | $962 |
| Pfizer | 50 | $812 |
| E.r. Squibb & Sons, L.L.C. | 46 | $734 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 17 | $518 |
| Johnson & Johnson | 27 | $487 |
| Amgen | 26 | $447 |
| Edwards Lifesciences | 5 | $390 |
| Philips North America LLC | 12 | $305 |
| Impulse Dynamics (USA) Inc. | 5 | $295 |
| Sanofi-aventis U.S. LLC | 13 | $270 |
| Boehringer Ingelheim | 14 | $250 |
| Merck | 11 | $177 |
| Alnylam Pharmaceuticals Inc. | 7 | $176 |
| Biosense Webster, Inc. | 1 | $146 |
| Kestra Medical Technology Services, Inc. | 5 | $120 |
| Bridgebio Pharma, Inc. | 4 | $107 |
| AstraZeneca | 6 | $103 |
| Baxter Healthcare | 2 | $64 |
| Inspire Medical Systems, Inc. | 1 | $54 |
| Bardy Diagnostics, Inc. | 2 | $54 |
| Abbott | 2 | $49 |
| Kiniksa Pharmaceuticals, Ltd. | 2 | $48 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $42 |
| Heartflow, Inc. | 2 | $41 |
| Actelion Pharmaceuticals US, Inc. | 2 | $38 |
| Esperion Therapeutics, Inc. | 2 | $37 |
| Daiichi Sankyo Inc. | 2 | $30 |
| Abiomed | 1 | $25 |
| Scpharmaceuticals Inc. | 1 | $22 |
| Bayer | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- WATCHMAN Access System$5,578
- SYNERGY ABLATION SYSTEM$1,532
- Watchman$1,169
- Micra$1,153
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$870
- OPTIMIZER$302
- ATRICLIP LAA EXCLUSION SYSTEM$236
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$185
- INSPIRIS RESILIA aortic valve$151
- Carto 3$146
- Farapulse$143
- XARELTO$120
How this compares
$18,338 in reported general payments places this provider in the 95th percentile of 766 medical providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 502 | $624,225 |
| XareltoRivaroxaban | 132 | $179,203 |
| MultaqDronedarone Hcl | 28 | $45,626 |
| EntrestoSacubitril/Valsartan | 31 | $33,001 |
| JardianceEmpagliflozin | 20 | $23,820 |
| Flecainide Acetate | 156 | $8,400 |
| BrilintaTicagrelor | 12 | $7,960 |
| Dofetilide | 47 | $7,350 |
| SotalolSotalol Hcl | 263 | $5,182 |
| Propafenone Hcl ErPropafenone Hcl | 26 | $4,692 |
| Metoprolol Succinate | 262 | $3,284 |
| Nebivolol Hcl | 46 | $2,732 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 73 | $1,901 |
| Potassium Chloride | 104 | $1,215 |
| Amlodipine Besylate | 102 | $704 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $812 | $624,225502 claims |
| Johnson & JohnsonXarelto | $487 | $179,203132 claims |
| Sanofi-aventis U.S. LLCMultaq | $270 | $45,62628 claims |
| NovartisEntresto | $962 | $33,00131 claims |
| Boehringer IngelheimJardiance | $250 | $23,82020 claims |
| AstraZenecaBrilinta | $103 | $7,96012 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 766 medical providers in Colorado.
Other medical in Colorado Springs
- Christen KutzColorado Springs$610K
- Kristin RyggColorado Springs$255K
- Michelle BarnettColorado Springs$138K
- Deanna JohnsonColorado Springs$41K
- Meghan CogswellColorado Springs$18K
- Amanda MixonFort Collins$342K
- Jordan MastDenver$247K
- John NovakAurora$173K
- Michael JacobsonFort Collins$131K
- Lindsey TunstallAurora$87K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.